Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
TGF-β trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance.
Journal: Journal for immunotherapy of cancer
Published: October 10, 2024
Hypothesis: AdAPT-001 and pseudoprogression - when seeing is not necessarily believing.
Journal: Journal for immunotherapy of cancer
Published: June 02, 2024
Lost at SCLC: a review of potential platinum sensitizers.
Journal: Cancer metastasis reviews
Published: April 02, 2024
Commentary on oncolytic viruses: past, present, and future.
Journal: Journal for immunotherapy of cancer
Published: November 30, 2023
CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency.
Journal: Breast cancer research : BCR
Published: November 29, 2023
TGF-β: the apex predator of immune checkpoints.
Journal: Future oncology (London, England)
Published: July 28, 2023
Predicting the Abscopal Phenomenon-Letter to the Editor.
Journal: Molecular cancer therapeutics
Published: June 24, 2023
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors.
Journal: Cancer gene therapy
Published: May 24, 2023
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.
Journal: Frontiers in oncology
Published: April 11, 2023
Data Management 101 for drug developers: A peek behind the curtain.
Journal: Clinical and translational science
Published: April 10, 2023
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma.
Journal: Frontiers in oncology
Published: February 28, 2023
Last Updated: 09/26/2026